Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Essential Properties Realty Trust Q3 AFFO, Revenue Rise; Raises 2026 Guidance; Issues 2027 Outlook

Essential Properties Realty Trust Q3 AFFO, Revenue Rise; Raises 2026 Guidance; Issues 2027 Outlook

MT newswireMT newswire2026/10/21 20:36
04:36 PM EDT, 10/21/2026 (MT Newswires) -- Essential Properties Realty Trust (EPRT) reported Q3 adjusted funds from operations late Wednesday of $0.51 per diluted share, up from $0.48 a year earlier. Analysts polled by FactSet expected $0.51. Revenue for the quarter ended Sept. 30 was $168.7 million, up from $144.9 million a year earlier. Analysts expected $158.2 million. The company raised its full-year 2026 AFFO per share guidance to $2.02 to $2.05 from $2.01 to $2.05 earlier. Analysts expect $2.04. Essential Properties said it currently expects 2027 AFFO per share of $2.10 to $2.18. Analysts expect $2.16.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12